Literature DB >> 33904018

In vitro cytotoxic effect of a chitin-like polysaccharide produced by Mortierella alpina on adrenocortical carcinoma cells H295R, and its use as mitotane adjuvant.

Luis Daniel Goyzueta Mamani1, Júlio Cesar de Carvalho2, Sandro J R Bonatto3, Valcineide A O Tanobe4, Carlos Ricardo Soccol1.   

Abstract

This study presents an in vitro evaluation of the antitumor potential of a chitin-like exopolysaccharide (EPS, produced by Mortierella alpina) on Adrenocortical carcinoma cells (ACC) compared to mitotane, a commercial drug commonly used in ACC treatment, and known for its side effects. Techniques of cellular viability determination such as MTT and fluorescence were used to measure the cytotoxic effects of the EPS and mitotane in tumoral cells (H295R) and non-tumoral cells (VERO), observing high cytotoxicity of mitotane and a 10% superior pro-apoptotic effect of the EPS compared to mitotane (p < 0.05). The cytotoxic effect of the EPS was similar to the effect of 50 μM mitotane on tumoral cells (p < 0.05). A decrement of the lysosomal volume was also noted in tumoral cells treated with the EPS. To enhance the antitumor effect, a combination of mitotane at a lower dosage and the EPS (as adjuvant) was also tested, showing a slight improvement of the cytotoxicity effect on tumoral cells. Therefore, the results indicate a cytotoxic effect of the EPS produced by Mortierella alpina on adrenocortical carcinoma, and a possible application in biomedical formulations or additional treatments.

Entities:  

Keywords:  Adrenocortical carcinoma; Anti-tumor effect; Exopolysaccharide; Mitotane; Mortierella alpina

Mesh:

Substances:

Year:  2021        PMID: 33904018     DOI: 10.1007/s11626-021-00560-y

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  5 in total

1.  Ultrasonic treatment for improved solution properties of a high-molecular weight exopolysaccharide produced by a medicinal fungus.

Authors:  Zhao-Mei Wang; Yi-Ching Cheung; Po-Hong Leung; Jian-Yong Wu
Journal:  Bioresour Technol       Date:  2010-02-19       Impact factor: 9.642

Review 2.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

Review 3.  Polysaccharides as potential anticancer agents-A review of their progress.

Authors:  Tabassum Khan; Amrita Date; Hardik Chawda; Krina Patel
Journal:  Carbohydr Polym       Date:  2019-01-29       Impact factor: 9.381

4.  Combination chemotherapy in advanced adrenocortical carcinoma.

Authors:  Martin Fassnacht; Massimo Terzolo; Bruno Allolio; Eric Baudin; Harm Haak; Alfredo Berruti; Staffan Welin; Carmen Schade-Brittinger; André Lacroix; Barbara Jarzab; Halfdan Sorbye; David J Torpy; Vinzenz Stepan; David E Schteingart; Wiebke Arlt; Matthias Kroiss; Sophie Leboulleux; Paola Sperone; Anders Sundin; Ilse Hermsen; Stefanie Hahner; Holger S Willenberg; Antoine Tabarin; Marcus Quinkler; Christelle de la Fouchardière; Martin Schlumberger; Franco Mantero; Dirk Weismann; Felix Beuschlein; Hans Gelderblom; Hanneke Wilmink; Monica Sender; Maureen Edgerly; Werner Kenn; Tito Fojo; Hans-Helge Müller; Britt Skogseid
Journal:  N Engl J Med       Date:  2012-05-02       Impact factor: 91.245

5.  Inhibition of pulmonary metastasis of Lewis lung carcinoma by a glucan, Schizophyllan.

Authors:  T Yamamoto; T Yamashita; E Tsubura
Journal:  Invasion Metastasis       Date:  1981
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.